Home › Funds › GLENVIEW CAPITAL MANAGEMENT, LLC › TECH
GLENVIEW CAPITAL MANAGEMENT, LLC position in TECH
BIO-TECHNE CORP · Health Care
GLENVIEW CAPITAL MANAGEMENT, LLC reported holding 58,324 shares of TECH (BIO-TECHNE CORP) in its Q2 2026 13F filing — a position valued at US$4.1M, representing 0.08% of its reported portfolio and ranking #44 among its reported holdings. GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed TECH holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GLENVIEW CAPITAL MANAGEMENT, LLC's TECH position evolved
GLENVIEW CAPITAL MANAGEMENT, LLC first disclosed a stake in TECH in Q3 2025 at 374,051 shares (US$20.8M). The position peaked in Q4 2025 at 619,944 shares, worth US$36.5M. Across 4 filings, GLENVIEW CAPITAL MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 58,324 shares valued at US$4.1M — a reduction of -127,988 shares quarter over quarter.. Notable position changes include a 66% increase in Q4 2025 (shares fell 11% over the following quarter), a 70% trim in Q1 2026 (shares rose 35% over the following quarter), a 69% trim in Q2 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 374.05K | $20.81M | New |
| Q4 2025 | 619.94K | $36.46M | Add |
| Q1 2026 | 186.31K | $9.74M | Reduce |
| Q2 2026 | 58.32K | $4.12M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECH and 13F data
TECH (BIO-TECHNE CORP) is a Health Care company. 29 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECH
- HBK INVESTMENTS L P 6.83M sh · $482.19M · Q2 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.35M sh · $236.60M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 3.16M sh · $223.52M · Q2 2026
- MAIRS & POWER INC 2.70M sh · $190.80M · Q2 2026
- WHITEBOX ADVISORS LLC 2.10M sh · $148.37M · Q2 2026
- RGM Capital, LLC 2.15M sh · $126.56M · Q4 2025
More on GLENVIEW CAPITAL MANAGEMENT, LLC
FAQ
How long has GLENVIEW CAPITAL MANAGEMENT, LLC held TECH?
GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed TECH holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in TECH?
As of Q2 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 58.32K shares of TECH (BIO-TECHNE CORP), valued at $4.12M, representing 0.08% of its reported portfolio and ranking #44.
Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling TECH?
In the latest 13F filing (Q2 2026), GLENVIEW CAPITAL MANAGEMENT, LLC reduced its position in TECH. The position peaked in Q4 2025 at 619.94K shares.
Which other funds hold TECH?
Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.